Founded in late 2016 as a project by academics associated with Precision Health Economics, IVI sought to influence HEOR practitioners, academics, payers, and value assessors through policy papers, commentaries, and convenings to advance novel approaches to value assessment that address key limitations in conventional cost-effectiveness analysis. Since inception, IVI has championed a focus on patient-centered outcomes and preferences as drivers of change, emphasized modern thinking about methods and value elements that should be included in value assessment models, and advocated for transparent, open-source model development to improve dialogue and build trust between users, decision-makers and patient communities. In 2018, IVI published its first Open-Source Value Project (OSVP) model. In 2018, IVI began the process of transition to a non-profit entity and the company was granted 501(c)(3) status in August 2019. Funding for IVI occurs through an organized membership program for organizations and individuals that spans patients, health systems, payers, and corporate life science companies.
Today, IVI is a 501(c)3 nonprofit research organization governed by our Board of Directors, with input from our Scientific Advisory Panel and our Patient Advisory Council. All Board members are required to disclose any potential conflicts of interest, and must recuse themselves from any decision involving a potential conflict. For a copy of our Conflict of Interest Policy, Nonprofit Determination Letter, Bylaws or 990, please contact email@example.com.
Learn more about our principles for value assessment in the US or visit our visit our FAQ section for additional information.